Clinical Trial Update: Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

View source ↗

Summary

Completed clinical trial evaluating Berodual Respimat inhalation solution in patients with Chronic Obstructive Pulmonary Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Berodual Respimat (ipratropium bromide and fenoterol hydrobromide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED